Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1CNS 1Breast 1

Conditions

Hereditary Breast and Ovarian Cancer Syndrome 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1251Specimen Handling 867Carboplatin 816Magnetic Resonance Spectroscopy 803Cyclophosphamide 794Cisplatin 715Nivolumab 646Paclitaxel 623Radiotherapy 564Gemcitabine 562Biopsy 529Bevacizumab 468Dexamethasone 433fludarabine 404Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 352Capecitabine 350atezolizumab 341Rituximab 326durvalumab 326Doxorubicin 313Radiosurgery 305Pemetrexed 302Drug Therapy 294Standard of Care 292Ipilimumab 289Etoposide 279Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Genotype × 1 year × Clear all
NCT07432308 2026-03-06

Liquid biopsy

Institute of Oncology Ljubljana

Phase NA Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05120284 2025-08-29

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

University of Florida

Phase 2 Active not recruiting
40 enrolled
CNS

Glioblastoma

NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡